Fintel reports that on July 21, 2025, TD Cowen downgraded their outlook for Centene (NYSE:CNC) from Buy to Hold. Analyst ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the ...

Effective and accessible healthcare were a core part of Centene’s mission. The company believed that every individual ...

Investing.com -- Shares of Centene (NYSE:CNC) plunged more than 32% in premarket trading Wednesday after the company pulled its 2025 guidance, citing unexpectedly poor risk adjustment results in ...

Centene Corporation (NYSE:CNC) experienced a challenging Tuesday evening, witnessing a 25% drop in shares during after-hours trading on July 1st. The significant decline in the healthcare giant's ...

On June 2, an analyst from Barclays downgraded Centene Corporation’s (NYSE:CNC) rating from Overweight to Equal-Weight and lowered its price target from $84 to $65. The downgrade follows Centene ...

Investing.com - UBS downgraded Centene (NYSE:CNC) stock rating from Buy to Neutral on Wednesday, slashing its price target to $45.00 from $80.00 following the healthcare company’s withdrawal of ...

Jefferies downgraded Centene (CNC) to Underperform from Hold with a price target of $52, down from $68. After analysis of Affordable Care Act Exchange data, the firm sees potential for ...

Humana, Elevance, Centene downgraded days before second-quarter earnings kickoff Major payers are facing downgrades amid rising Medicare Advantage and commercial cost pressures. Published July 13 ...

This revision was in response to Centene's slight increase in its 2024 EPS guidance by approximately 1.5%, despite a roughly 0.40% miss in the Medicaid Medical Loss Ratio.